Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome

Natalia Zeber-Lubecka , Maria Kulecka , Filip Ambroźkiewicz , Agnieszka Paziewska , Krzysztof Goryca , Jakub Kaczmarski , Tymon Rubel , Wojciech Wojtowicz , Piotr Młynarz , Łukasz Marczak , Roman Tomecki , Michał Mikuła , Jerzy Ostrowski

Abstract

n/a
Author Natalia Zeber-Lubecka
Natalia Zeber-Lubecka,,
-
, Maria Kulecka
Maria Kulecka,,
-
, Filip Ambroźkiewicz
Filip Ambroźkiewicz,,
-
, Agnieszka Paziewska
Agnieszka Paziewska,,
-
, Krzysztof Goryca
Krzysztof Goryca,,
-
, Jakub Kaczmarski
Jakub Kaczmarski,,
-
, Tymon Rubel IRTM
Tymon Rubel,,
- The Institute of Radioelectronics and Multimedia Technology
, Wojciech Wojtowicz
Wojciech Wojtowicz,,
-
, Piotr Młynarz
Piotr Młynarz,,
-
, Łukasz Marczak
Łukasz Marczak,,
-
et al.
Journal seriesGut Microbes, ISSN 1949-0976, e-ISSN 1949-0984
Issue year2016
Vol7
No5
Pages397-413
Publication size in sheets0.8
URL http://dx.doi.org/10.1080/19490976.2016.1215805
Languageen angielski
Score (nominal)5
ScoreMinisterial score = 0.0, 27-03-2017, ArticleFromJournal
Ministerial score (2013-2016) = 5.0, 27-03-2017, ArticleFromJournal
Citation count*7 (2018-02-19)
Cite
Share Share



* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.
Back